NewAmsterdam Pharma N.V.
NAMS | NASDAQ
$23.44
+$0.86 (+3.81%)
Sep 22, 2026, 12:40 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 490M | 771.74M | 340.45M | 467.73M | 60.38M | 1.37M |
Short-Term Investments | 146.24M | 62.45M | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 138M |
Other Long-Term Assets | 92.61M | n/a | 35K | 156K | 816.56K | n/a |
Receivables | 23.15M | 21.31M | 1.88M | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.32M | n/a | n/a | 2.07M | 4.88M | n/a |
Total Current Assets | 675.7M | 863.41M | 346.79M | 477.98M | 66.96M | 1.87M |
Property-Plant & Equipment | 568K | 673K | 101K | 154K | 216.08K | n/a |
Goodwill & Intangibles | 407K | 534K | 170K | 208K | n/a | n/a |
Total Long-Term Assets | 93.58M | 1.21M | 306K | 518K | 1.03M | 138M |
Total Assets | 769.28M | 864.62M | 347.1M | 478.5M | 67.99M | 139.87M |
Account Payables | 8.97M | 4.74M | 16.92M | 11.85M | 7.07M | 162.48K |
Deferred Revenue | 3.99M | 6.01M | 8.94M | n/a | n/a | n/a |
Short-Term Debt | 136K | 246K | n/a | n/a | n/a | n/a |
Other Current Liabilities | 72.69M | 91.03M | 15.96M | 18.02M | 519.69K | 74.04K |
Total Current Liabilities | 85.79M | 106.92M | 49.9M | 36.06M | 11.24M | 236.52K |
Long-Term Debt | 66K | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | 7.79M | 12.31M | n/a | 12.17M |
Total Long-Term Liabilities | 66K | 202K | 8.81M | 12.37M | 126.24K | 12.17M |
Total Liabilities | 85.85M | 107.12M | 58.7M | 48.43M | 11.36M | 12.41M |
Total Debt | 202K | 448K | 60K | 126K | 186.51K | n/a |
Book Value | 683.43M | 757.5M | 288.39M | 430.07M | 56.63M | 127.46M |
Book Value Per Share | 5.97 | 8.03 | 3.51 | 22.68 | 3.19 | 7.18 |
Common Stock | 14.28M | 13.44M | 10.17M | 10.06M | 128.51K | 122.46M |
Retained Earnings | -762.39M | -558.57M | -316.97M | -140.04M | -39.44M | 41.45K |
Comprehensive Income | 4.79M | 4.47M | 4.42M | 4.42M | 672.13K | n/a |
Shareholders Equity | 683.43M | 757.5M | 288.39M | 430.07M | 56.63M | 127.46M |
Total Investments | 146.24M | 62.45M | n/a | n/a | n/a | 138M |
Add to Watchlist
Select watchlists to add or remove NAMS